UC-MSC Stem Cell Therapy for Autoimmune Diseases: A Regenerative Hope

Umbilical cord mesenchymal stem cell (UC-MSC) therapy is offered in Thailand, mostly in Bangkok, for autoimmune diseases such as lupus, multiple sclerosis and psoriasis. It is still investigational. Under Thai rules, it should only be given within an approved research protocol. The strongest evidence so far is for lupus that does not respond to standard drugs. For most other conditions the evidence is much weaker.

This guide is for patients and families weighing their options. It covers who may be a good candidate, which tests to bring, how the cells are given, what a 1 to 3 week stay in Bangkok looks like, and the realistic costs and risks. It also gives an honest evidence level for each condition.

What Is UC-MSC Stem Cell Therapy for Autoimmune Disease?

In an autoimmune disease, the immune system attacks the body’s own tissues. Lupus can damage the kidneys, skin and joints. Multiple sclerosis damages the protective coating of nerves. Psoriasis drives inflammation in the skin and sometimes the joints. Standard treatments, such as steroids, immunosuppressants and biologic drugs, dampen the immune system to control the attack. Many patients do well on them. Some keep having flares, or cannot tolerate the side effects.

Mesenchymal stem cells (MSCs) are cells that can calm and rebalance the immune system. UC-MSCs come from the Wharton’s jelly of umbilical cords donated after healthy births. A laboratory screens them and grows them to a treatment dose. Researchers think they work mainly by releasing signals rather than by replacing damaged tissue. In lupus studies, for example, they raised the level of regulatory T cells, which help keep the immune system in check, and restored a better balance of inflammatory signals.

Umbilical cord cells have a few practical advantages over cells taken from your own bone marrow or fat:

• No harvesting procedure. You do not need a bone marrow or fat extraction.

• Young, active cells. Cord cells come from newborn tissue. In some autoimmune diseases, the patient’s own MSCs work less well.

• Low immune reaction. They rarely trigger rejection, so tissue matching is not needed.

• Ready in advance. They can be prepared and quality-tested before you arrive.

The main trade-off is that the results depend heavily on the quality and standards of the laboratory that grows them.

Is Stem Cell Therapy for Autoimmune Disease Legal in Thailand?

It is legal only within approved research. Thailand allows routine stem cell treatment for a short list of blood disorders, such as leukaemia, lymphoma, aplastic anaemia and thalassemia. Any other use, including for autoimmune disease, must go through a research protocol. The protocol has to be approved by the Medical Council of Thailand and the hospital’s ethics committee, and carried out by licensed doctors at approved institutions. Thai officials have stated that stem cell injections outside these permitted uses, when openly advertised by clinics, are illegal (The Nation, October 2024).

The rules are tightening further. A Ministry of Public Health decree under the Drug Act now classifies expanded cells such as MSCs as Advanced Therapy Medicinal Products (ATMPs). These must be made in GMP-certified facilities that meet PIC/S standards and must be registered with the Thai FDA (The Nation, May 2026). For patients, this should mean better-controlled products over time. It also means you should check carefully that any provider is working within the law.

Stem Cell Therapy for Autoimmune Disease in Bangkok: How to Check a Clinic

Most providers in Thailand are in Bangkok. Before you book, ask the clinic for:

• the approval number of its research protocol, from the Medical Council and an ethics committee

• the licence of the laboratory that grows the cells, and its GMP certification

• the name and specialty of the doctor in charge, ideally a rheumatologist, neurologist or dermatologist

• a certificate of analysis for your batch of cells, showing cell count, viability, sterility and endotoxin testing

• a written consent form that describes the treatment as research and lists the risks

A clinic that cannot show these documents, guarantees results, or calls the treatment a cure is a warning sign. Hold out for a provider that answers these questions clearly and in writing.

Who Is a Good Candidate for Stem Cell Therapy for Autoimmune Disease?

The patients studied most are adults whose disease stays active despite standard treatment. In the main lupus study, patients had active disease after at least 6 months of drugs such as intravenous cyclophosphamide or mycophenolate (Wang et al., 2014).

You may be a candidate if:

• a specialist has confirmed your diagnosis

• your disease is still active despite standard treatment, or you cannot tolerate standard drugs

• your treating doctor at home agrees to share your records and stay involved in your care

• you are well enough to travel and stay in Bangkok for 1 to 3 weeks

• you understand that the treatment is investigational and that results are not guaranteed

You are usually not a candidate if you have:

• an uncontrolled infection

• active cancer

• severe heart failure, or failure of a vital organ

• pregnancy, or you are breastfeeding

These match the exclusion criteria used in the multicentre lupus trial. Your own doctor’s support is important. The most valuable part of the treatment, monitoring your response and adjusting your medicines, happens after you go home.

What Tests Are Needed Before Stem Cell Therapy for Autoimmune Disease?

Bring recent results, ideally from the last 3 months. They let the medical team confirm your diagnosis, measure how active your disease is, and screen for risks before treatment.

The clinic may repeat some tests when you arrive. Translated copies of key reports in English help, and so do digital copies of imaging.

Stem Cell Treatment for Autoimmune Disease: What to Expect

Most programmes follow the same five steps. Each clinic’s protocol is a little different, so ask for a written day-by-day plan before you travel.

• Remote review, before travel: You send your records and test results. A doctor checks whether you fit the protocol, and decides the dose and how the cells should be given.

• Arrival and assessment, days 1 to 2: You have a physical exam, repeat blood tests and a consent discussion. The doctor confirms your dose, which is usually calculated from your body weight.

• Cell treatment, days 2 to 10: You receive one or more doses of UC-MSCs. In the multicentre lupus study, patients received two intravenous infusions a week apart, on day 0 and day 7 (Wang et al., 2014). An IV infusion usually takes 30 to 60 minutes, followed by a few hours of observation.

• Monitoring, throughout your stay: You are checked daily for fever, headache, allergic reaction and signs of infection. Blood tests may be repeated before discharge.

• Follow-up at home, at months 1, 3, 6 and 12: Your own specialist repeats your disease activity tests and shares the results with the treating team.

How Long Does Stem Cell Treatment for Autoimmune Disease Take?

Plan to stay in Bangkok for 1 to 3 weeks. A single IV course may need only about a week. Two doses a week apart usually need 2 to 3 weeks. So does an intrathecal dose for multiple sclerosis, which needs extra observation.

The effect takes much longer than the stay. In lupus studies, changes in disease activity scores and kidney markers were tracked over 3 to 12 months. Some patients relapsed after about 6 months, and the researchers suggested that repeat infusions may be needed (Wang et al., 2014). Before you commit, ask the clinic whether a second course is likely and what it would cost.

IV vs Intrathecal Stem Cells for Autoimmune Disease

How the cells are given depends on where the disease is. Most autoimmune conditions affect the whole body, so the cells are usually given intravenously. Intrathecal injection is mainly studied for multiple sclerosis, because it delivers cells directly into the fluid around the brain and spinal cord. Local injection is sometimes used where one area, such as a joint, is most affected.

Is Intrathecal Better Than IV for Multiple Sclerosis?

The evidence is mixed. In a 48-patient randomized, sham-controlled trial in progressive MS, both IV and intrathecal MSCs reduced treatment failure compared with sham. The intrathecal route did better than IV on several measures (Petrou et al., 2020). However, a later Norwegian placebo-controlled trial found no regenerative effect from a single intrathecal dose. It also saw local inflammatory reactions and advised caution (SMART-MS). Both trials used patients’ own bone marrow MSCs, not umbilical cord cells. That is worth discussing with your neurologist before choosing a route.

What Does the Evidence Show for Each Autoimmune Disease?

The evidence differs a great deal from one condition to another. None of these uses is an approved standard treatment, and no study has shown a cure.

Evidence levels: Moderate means randomized controlled trials with consistent results. Low means small or uncontrolled studies. Very low means no human trials.

Stem Cell Therapy for Lupus in Thailand

Lupus has the most research behind it. In a multicentre study across four centres, 40 patients with active, treatment-resistant lupus received UC-MSCs by IV on days 0 and 7. The infusions were well tolerated, with no transplant-related adverse events. Disease activity scores improved, and in patients with lupus nephritis, 24-hour urine protein fell over 9 to 12 months. Several patients relapsed after 6 months (Wang et al., Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study, 2014).

That study had no comparison group, so it cannot show how much of the improvement came from the cells. A small randomized, double-blind, placebo-controlled trial later tested UC-MSCs on top of standard drugs for lupus nephritis. Remission rates were similar in both groups, and the trial was stopped early (Deng et al., 2017). A French phase 1/2 trial, Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord, is testing IV doses of 1, 2 and 4 million cells per kg, mainly for safety.

UC-MSCs may help some people with lupus that resists standard drugs, but controlled trials have not yet confirmed this. They are best seen as an add-on considered with your rheumatologist, not a replacement for proven treatment.

Stem Cell Therapy for Multiple Sclerosis in Thailand

The best MS data come from bone marrow MSCs rather than cord cells. A 48-patient double-blind trial reported fewer treatment failures with MSCs than with sham injections, especially in patients with active disease (Petrou et al., 2020). A later trial of a single intrathecal dose found no regenerative benefit (SMART-MS). Whether umbilical cord cells work the same way is unknown. People with relapsing MS should know that several approved disease-modifying drugs have strong evidence. Stem cell therapy should not replace them.

Stem Cell Therapy for Psoriasis in Thailand

In a phase 1/2a study, 17 patients with psoriasis received IV UC-MSCs. No obvious side effects were seen during treatment or over 6 months of follow-up. About half (8 of 17) improved their psoriasis severity score by at least 40%, and 3 had little or no remaining disease (Cheng et al., 2022). There was no comparison group, so these results are early. Today’s biologic drugs for psoriasis have much stronger evidence, and that is worth weighing.

Stem Cell Therapy for Hashimoto’s Thyroiditis

In rats with autoimmune thyroiditis, UC-MSCs reduced thyroid inflammation and antibody levels. We found no published human trials. Hashimoto’s is usually well controlled with a daily thyroid hormone tablet. Stem cell therapy for Hashimoto’s should only be offered within a registered clinical trial.

Other Autoimmune Conditions

Rheumatoid arthritis, Crohn’s disease and NK cell therapy are covered in detail on their own pages:

• Stem cell therapy for rheumatoid arthritis

• Stem cell therapy for Crohn’s disease

• NK cell therapy

For the science of how UC-MSCs affect the immune system, see our in-depth article, UC-MSC stem cell therapy for autoimmune diseases.

Can I Stop Immunosuppressants After Stem Cell Therapy?

Not on your own, and not right away. In the lupus studies, patients stayed on their usual medicines, and their doctors decided any reductions based on test results (Wang et al., 2014). Stopping steroids suddenly can cause a dangerous adrenal crisis. Stopping other immunosuppressants can trigger a serious flare.

If your disease improves over the following months, your own rheumatologist or neurologist may lower your doses step by step. That decision belongs at home, with regular blood tests, not during your stay in Thailand. Be wary of any provider who tells you to stop prescribed medicines before or after cell therapy.

Is Stem Cell Therapy for Autoimmune Disease Safe in Thailand?

In published studies, UC-MSC infusions have generally been well tolerated. Common short-term side effects include:

• fever or chills on the day of infusion

• headache and tiredness

• after intrathecal injection: headache, back pain and short-lived nerve irritation

Serious problems are uncommon but possible. In the small placebo-controlled lupus trial, one patient in the stem cell group developed pneumonia and a skin abscess, and another died of severe pneumonia (Deng et al., 2017). It is not clear whether the cells caused these infections. However, people with autoimmune disease who take immunosuppressants already have a higher risk of infection, so careful screening and monitoring matter. Long-term risks, beyond a few years, are not yet well known.

In Thailand, the biggest safety factor you control is your choice of provider. Make sure that:

• the treatment runs under an approved research protocol

• the cells come from a GMP-certified laboratory, with batch testing you can see

• a specialist in your condition is in charge of your care

• the clinic has a clear plan for emergencies and for follow-up after you go home

How Much Does Stem Cell Therapy for Autoimmune Disease Cost in Thailand?

Prices vary widely between providers. The main factors are:

• cell dose: the number of cells per dose and the number of doses

• route: intrathecal injection costs more than IV because it needs a procedure room and a specialist

• stay and tests: the length of your stay and which tests are included

• follow-up treatment: whether repeat courses are expected, as lupus studies suggest they may be

Because the treatment is investigational, health insurance rarely covers it. Ask every provider for a written, itemised quote covering cell dose, number of treatments, tests, doctor fees, hospital or clinic stay, and follow-up. Then you can compare offers fairly. Also budget for flights, accommodation and a companion, since you may feel tired after treatment.

Questions to Ask Before You Decide

Take this list to your consultation:

1. What does the evidence show for my specific disease, and how many patients like me have you treated?

The evidence depends on your disease:

• Lupus: the strongest data so far, but mixed. An open-label study of 40 patients showed improvement. A small placebo-controlled trial found no added benefit over standard drugs.

• Multiple sclerosis: mixed results, mostly from bone marrow cells rather than cord cells.

• Psoriasis: one small study of 17 patients, in which about half improved.

• Hashimoto’s thyroiditis: animal studies only.

Under our protocol, we have treated [number] patients with [condition] since [year]. We follow up every patient at 1, 3, 6 and 12 months. We will share our anonymised results with you, including patients who did not improve, so you can see a realistic picture rather than our best cases.

2. How many cells, how many doses, and by which route?

The dose depends on your body weight and condition. Our protocol uses [e.g. 1 to 2 million cells per kg] per dose. Published lupus and psoriasis studies used doses in a similar range.

• Lupus, psoriasis and most whole-body conditions: usually [1 to 2] IV infusions, about a week apart, each taking 30 to 60 minutes.

• Multiple sclerosis: IV, intrathecal (lumbar puncture), or both, depending on your neurologist’s advice and your MRI findings.

• Local joint or skin involvement: local injection may be added.

Before treatment, you will receive a written plan with your exact dose, route and schedule, and a certificate of analysis for your batch of cells (cell count, viability and sterility).

3. What results do you track, and how will you share them with my doctor at home?

We measure the same markers your specialist already uses, so results are easy to compare:

• Lupus: disease activity score (SLEDAI), anti-dsDNA, complement C3/C4, urine protein and kidney function

• Multiple sclerosis: disability score (EDSS), relapses and MRI

• Psoriasis: psoriasis severity score (PASI) and photos

• All patients: blood count, liver and kidney function, and any side effects

You will leave with a discharge summary in English. With your consent, we send it directly to your home doctor. We ask your doctor to share repeat test results at months 1, 3, 6 and 12, and our team will review them with you by video call.

4. What happens if I have a reaction or an infection during or after treatment?

During your stay: a doctor and nurses monitor you during and after every infusion. Emergency drugs and equipment are kept on site. Fever and headache are the most common reactions and usually settle within a day with simple treatment. For serious problems, we transfer you to partner hospital in Bangkok.

Get an Honest Review of Your Case

Not sure whether you are a candidate? Send us your specialist’s letter, current medication list and recent blood tests via WhatsApp or our consultation form. Our doctors will tell you whether your condition fits an approved protocol, what the evidence says for your disease, and what a realistic plan and budget look like. That includes telling you when stem cell therapy is not the right choice.

This article is for general information. It does not replace advice from your own doctor. Do not change or stop any medicine without your doctor’s guidance.

Sources

• Wang D, et al. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Research & Therapy, 2014.

• Assistance Publique – Hôpitaux de Paris. Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord (NCT03562065). ClinicalTrials.gov.

• Deng D, et al. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Annals of the Rheumatic Diseases, 2017.

• Petrou P, et al. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain, 2020.

• Kvistad CE, et al. Intrathecal mesenchymal stem cells in progressive multiple sclerosis (SMART-MS).

• Cheng L, et al. Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study. Signal Transduction and Targeted Therapy, 2022.

• hUC-MSCs in experimental autoimmune thyroiditis (rat study).

• The Nation. Caution should be the watchword for patients seeking stem cell therapy, October 2024.

• The Nation. Thailand classifies stem cell therapies as medicines, May 2026.